RxDoctor Payments Data

Lisa Dillard, MD

Internal Medicine · Marietta, GANPI 1831153212

Payments from drug & device makers

$3,798in general payments, 2019–2025

Across 209 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$848
  • Lilly USA, LLC$504
  • Pfizer$388
  • AbbVie$232
  • AstraZeneca$220
  • Boehringer Ingelheim$215
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,75399%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,798 in reported general payments places this provider in the 80th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$83,582
Medicare patients
217
Services billed
1,123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide89$112,165
JardianceEmpagliflozin68$77,459
MounjaroTirzepatide36$40,648
EliquisApixaban35$25,362
JanuviaSitagliptin Phosphate24$24,040
FarxigaDapagliflozin Propanediol30$23,535
TrulicityDulaglutide12$18,568
PremarinEstrogens, Conjugated16$7,605
Atorvastatin Calcium334$3,390
Novolog FlexpenInsulin Aspart13$3,004
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,961
SynthroidLevothyroxine Sodium32$2,468
Valsartan102$2,436
Rosuvastatin Calcium212$2,158
Levothyroxine Sodium227$2,009

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$848$112,16589 claims
Boehringer IngelheimJardiance$215$77,45968 claims
Lilly USA, LLCMounjaro, Trulicity$504$59,21548 claims
PfizerEliquis, Premarin$388$32,96751 claims
MerckJanuvia$75$24,04024 claims
AstraZenecaFarxiga$220$23,53530 claims
AbbVieSynthroid$232$2,46832 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →